This proposal to examine the molecular basis of cholecystokinin (CCK) receptor structure, function, and regulation supports the long-term goal of understanding the roles of this gastrointestinal hormone in health and disease. CCK is important for nutrient assimilation, with roles in regulating post-cibal pancreatic secretion, gallbladder emptying, gut transit, and satiety. The general underlying hypothesis is that understanding the CCK receptor requires insights into its global structure and molecular interactions throughout its dynamic life. Component aims are directed to each of three key CCK receptor domains, (i) the external face that is responsible for ligand binding, (ii) the internal face that is important for signal initiation and receptor regulation, and (iii) the intramembranous face that represents a potential site for interactions with other membrane proteins.
Each aim i s driven by hypotheses dealing with current concepts of functions and interactions that might occur at that site, with relevance for mechanisms of pharmacoregulation.
Aim 1 examines the hypothesis that ligands with distinct chemical structures can induce similar global receptor conformations by interacting with distinct receptor domains. Studies utilize photoaffinity labeling, receptor mutagenesis, and fluorescence transfer techniques to gain insights into the binding of peptide and non-peptidyl agonists and antagonists.
Aim 2 explores the hypothesis that receptor phosphorylation exposes previously hidden receptor domains that can interact with regulatory molecules. Studies utilize over- expression competition strategies to identify important cytosolic domains, and use biochemical and molecular biological techniques to identify molecules interacting with these.
Aim 3 explores intramembranous interactions with the receptor that could have functional significance. Bioluminescence resonance energy transfer and cross-linking techniques are utilized. The proposed work builds on the unique strengths and experience of the laboratory and the tools that have been developed and extensively characterized in previous cycles of this grant. Together, these studies should provide the finest level of molecular detail yet available for the structure, mechanism of binding, and mechanisms of regulation of any peptide hormone receptor in this superfamily, while providing insights useful for the development and refinement of receptor- and cell-specific therapeutic intervention.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37DK032878-24
Application #
6935167
Study Section
General Medicine A Subcommittee 2 (GMA)
Program Officer
Hamilton, Frank A
Project Start
1983-08-01
Project End
2006-07-31
Budget Start
2005-08-01
Budget End
2006-07-31
Support Year
24
Fiscal Year
2005
Total Cost
$454,015
Indirect Cost
Name
Mayo Clinic, Arizona
Department
Type
DUNS #
153665211
City
Scottsdale
State
AZ
Country
United States
Zip Code
85259
Desai, A J; Dong, M; Harikumar, K G et al. (2016) Cholecystokinin-induced satiety, a key gut servomechanism that is affected by the membrane microenvironment of this receptor. Int J Obes Suppl 6:S22-S27
Desai, Aditya J; Dong, Maoqing; Miller, Laurence J (2016) Beneficial effects of ?-sitosterol on type 1 cholecystokinin receptor dysfunction induced by elevated membrane cholesterol. Clin Nutr 35:1374-1379
Harikumar, Kaleeckal G; Miller, Laurence J (2015) Use of Fluorescence Indicators in Receptor Ligands. Methods Mol Biol 1335:115-30
Desai, Aditya J; Lam, Polo C H; Orry, Andrew et al. (2015) Molecular Mechanism of Action of Triazolobenzodiazepinone Agonists of the Type 1 Cholecystokinin Receptor. Possible Cooperativity across the Receptor Homodimeric Complex. J Med Chem 58:9562-77
Desai, Aditya J; Dong, Maoqing; Harikumar, Kaleeckal G et al. (2015) Impact of ursodeoxycholic acid on a CCK1R cholesterol-binding site may contribute to its positive effects in digestive function. Am J Physiol Gastrointest Liver Physiol 309:G377-86
Dong, Maoqing; Vattelana, Ashton M; Lam, Polo C-H et al. (2015) Development of a highly selective allosteric antagonist radioligand for the type 1 cholecystokinin receptor and elucidation of its molecular basis of binding. Mol Pharmacol 87:130-40
Desai, Aditya J; Henke, Brad R; Miller, Laurence J (2015) Elimination of a cholecystokinin receptor agonist 'trigger' in an effort to develop positive allosteric modulators without intrinsic agonist activity. Bioorg Med Chem Lett 25:1849-55
Desai, Aditya J; Harikumar, Kaleeckal G; Miller, Laurence J (2014) A type 1 cholecystokinin receptor mutant that mimics the dysfunction observed for wild type receptor in a high cholesterol environment. J Biol Chem 289:18314-26
Dong, Maoqing; Miller, Laurence J (2013) Direct demonstration of unique mode of natural peptide binding to the type 2 cholecystokinin receptor using photoaffinity labeling. Peptides 46:143-9
Harikumar, Kaleeckal G; Potter, Ross M; Patil, Achyut et al. (2013) Membrane cholesterol affects stimulus-activity coupling in type 1, but not type 2, CCK receptors: use of cell lines with elevated cholesterol. Lipids 48:231-44

Showing the most recent 10 out of 131 publications